Antivirals in medical biodefense
Autor: | P. Zanetta, Marcella Bassetto, F. Hucke, Andrea Brancale, Joachim Jakob Bugert |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Orthobunyavirus viruses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Biology Antiviral Agents 03 medical and health sciences Medical microbiology Virology medicine Genetics Humans Antiviral treatment Intensive care medicine Molecular Biology 030304 developmental biology 0303 health sciences Biodefense 030306 microbiology Poxviridae Public health Outbreak Deliberate release General Medicine Filoviridae Orthomyxoviridae Bioterrorism Virus Diseases Infectious disease (medical specialty) Paramyxovirinae Arboviruses |
Zdroj: | Virus Genes |
ISSN: | 1572-994X 0920-8569 |
DOI: | 10.1007/s11262-020-01737-5 |
Popis: | The viruses historically implicated or currently considered as candidates for misuse in bioterrorist events are poxviruses, filoviruses, bunyaviruses, orthomyxoviruses, paramyxoviruses and a number of arboviruses causing encephalitis, including alpha- and flaviviruses. All these viruses are of concern for public health services when they occur in natural outbreaks or emerge in unvaccinated populations. Recent events and intelligence reports point to a growing risk of dangerous biological agents being used for nefarious purposes. Public health responses effective in natural outbreaks of infectious disease may not be sufficient to deal with the severe consequences of a deliberate release of such agents. One important aspect of countermeasures against viral biothreat agents are the antiviral treatment options available for use in post-exposure prophylaxis. These issues were adressed by the organizers of the 16th Medical Biodefense Conference, held in Munich in 2018, in a special session on the development of drugs to treat infections with viruses currently perceived as a threat to societies or associated with a potential for misuse as biothreat agents. This review will outline the state-of-the-art methods in antivirals research discussed and provide an overview of antiviral compounds in the pipeline that are already approved for use or still under development. |
Databáze: | OpenAIRE |
Externí odkaz: |